CAG repeats in the androgen receptor gene are shorter in patients with pulmonary, esophageal or bladder carcinoma and longer in women with uterine leiomyoma

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 811-818

  Teng, Xiao Ying ^a   Liu, Gui Qiu ^b   Diao, Xiao Li ^b   Wu, Zong Yong ^a   Li, Lan ^a   Zhang, Wei ^b   Zhang, Xun ^a   Su, Qin ^a,b  

^a CANCER HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Androgen receptor gene; Bladder; CAG repeat polymorphism; Carcinoma; Esophagus; Lung; Uterine leiomyoma

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CAG REPEAT; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA POLYMORPHISM; ESOPHAGUS CARCINOMA; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT TANDEM REPEAT; UTERUS MYOMA;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LEIOMYOMA; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS; URINARY BLADDER NEOPLASMS; UTERINE NEOPLASMS;

EID: 77349107161     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000702     Document Type: Article

References (70)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Pisani P, Parkin D, Bray F and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 18-29, 1999.
3. Gabbert HE, Shimoda T and Hainaut P: Squamous cell carcinoma. In: World Health Organization Classification. Pathology and Genetics of Tumors of The Digestive System. Hamilton SR and Aaltonen LA (eds). IARC Press, Lyon, pp11-19, 2000.
4. Fairlamb D and Boesen E: Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung. Br Med J 53: 269-271, 1977.
5. Kaiser U, Hofmann J, Schilli M, Wegmann B, Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gazdar AF and Havemann K: Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 67: 357-364, 1996.
6. Tihan T, Harmon JW, Wan X, Younes Z, Nass P, Duncan KL and Duncan MD: Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 21: 3107-3114, 2001.
7. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM and Chang C: Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99: 558-568, 2007.
8. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS and Wilson EM: Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240: 327-330, 1988.
9. Chang CS, Kokontis J and Liao ST: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240: 324-326, 1988.
10. Chamberlain NL, Driver ED and Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22: 3181-3186, 1994.
11. Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C and Haelens A: Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal 6: e008, 2008.
12. Ferro P, Catalano MG, Dell'Eva R, Fortunati N and Pfeffer U: The androgen receptor CAG repeat: a modifier of carcinogenesis? Mol Cell Endocrinol 193: 109-120, 2002.
13. Alevizaki M, Cimponeriu AT, Garofallaki M, Sarika HL, Alevizaki CC, Papamichael C, Philippou G, Anastasiou EA, Lekakis JP and Mavrikakis M: The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol 59: 749-755, 2003.
14. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM and Catterall JF: Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81: 4400-4405, 1996.
15. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH and Kantoff PW: The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94: 3320-3323, 1997.
16. Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM and Leach RJ: Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. J Urol 168: 2245-2248, 2002.
17. Santarosa M, Bidoli E, Gallo A, Steffan A, Boiocchi M and Viel A: Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer. Oncol Rep 9: 639-644, 2002.
18. Li AJ, Baldwin RL and Karlan BY: Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma. Clin Cancer Res 9: 3667-3673, 2003.
19. Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, Halabi S, Calingaert B, Gusberg A, Marks JR and Berchuck A: Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 16: 473-480, 2007.
20. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD, Chen PJ, Liu CJ and Chen CJ: Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92: 2023-2028, 2000.
21. Suter NM, Malone KE, Daling JR, Doody DR and Ostrander EA: Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12: 127-135, 2003.
22. Sasaki M, Dahiya R, Fujimoto S, Ishikawa M and Oshimura M: The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Mol Carcinog 27: 237-244, 2000.
23. Houston KD, Hunter DS, Hodges LC and Walker CL: Uterine leiomyomas: mechanisms of tumorigenesis. Toxicol Pathol 29: 100-104, 2001.
24. Cai Y-R, Diao X-L, Wang S-F, Zhang W, Zhang H-T and Su Q: X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas. Int J Oncol 31: 1379-1389, 2007.
25. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM and Belmont JW: Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51: 1229-1239, 1992.
26. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM and French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271-321, 1995.
27. Bain DL, Heneghan AF, Connaghan-Jones KD and Miura MT: Nuclear receptor structure: implications for function. Annu Rev Physiol 69: 201-220, 2006.
28. Dehm SM and Tindall DJ: Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol 21: 2855-2863, 2007.
29. Palazzolo I, Gliozzi A, Rusmini P, Sau D, Crippa V, Simonini F, Onesto E, Bolzoni E and Poletti A: The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol 108: 245-253, 2008.
30. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G and Pinsky L: Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 5: 184-188, 1993.
31. Kazemi-Esfarjani P, Trifiro MA and Pinsky L: Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG) n-expanded neuronopathies. Hum Mol Genet 4: 523-527, 1995.
32. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L and Yong EL: Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777-3782, 1997.
33. Zitmann M and Nieschlag E: The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26: 76-83, 2003.
34. Rajender S, Singh L and Thangaraj K: Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 9: 147-179, 2007.
35. Patrizio P, Leonard DG, Chen KL, Hernandez-Ayup S and Trounson AO: Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl 22: 444-448, 2001.
36. Katagiri Y, Neri QV, Takeuchi T, Moy F, Sills ES and Palermo GD: Androgen receptor CAG polymorphism (Xq11-12) status and human spermatogenesis: a prospective analysis of infertile males and their offspring conceived by intracytoplasmic sperm injection. Int J Mol Med 18: 405-413, 2006.
37. La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, Yee WC and Fischbeck KH: Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 2: 301-304, 1992.
38. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA and Ostrander EA: Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57: 1194-1198, 1997.
39. Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL and Brown M: Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64: 1371-1377, 1999.
40. Giguere Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J and Rousseau F: Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61: 5869-5874, 2001.
41. Liede A, Zhang W, De Leon Matsuda ML, Tan A and Narod SA: Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines. Cancer Epidemiol Biomarkers Prev 12: 848-852, 2003.
42. González A, Javier DF, Rodriguez G, Brito B, Rodríguez MA, Cabrera A, Díaz-Chico JC, Reyes R, Aguirre-Jaime A and Nicolás Díaz-Chico B: Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene. Eur J Cancer 43: 2373-2380, 2007.
43. Yaron M, Levy T, Chetrit A, Levavi H, Sabah G, Schneider D, Halperin R, Ben-Rafael Z and Friedman E: The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma. Cancer 92: 1190-1194, 2001.
44. Sasaki M, Sakuragi N and Dahiya R: The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients. Biochem Biophys Res Commun 305: 1105-1108, 2003.
45. Momas I, Daures J, Festy B, Bontoux J and Gremy F: Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 10: 599-604, 1994.
46. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK and Yu MC: Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93: 538-545, 2001.
47. Boffetta P: Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol (Suppl): 45-54, 2008.
48. Pelucchi C, Gallus S, Garavello W, Bosetti C and La Vecchia C: Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17: 340-344, 2008.
49. Dietzsch E, Laubscher R and Parker MI: Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene. Int J Cancer 107: 38-45, 2003.
50. Liu CH, Huang JD, Huang SW, Hour TC, Huang YK, Hsueh YM, Chiou HY, Lee TC, Jan KY, Chen CJ and Pu YS: Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma. J Biomed Sci 15: 261-269, 2008.
51. Okolo S: Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22: 571-588, 2008.
52. Blake RE: Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc 99: 1170-1184, 2007.
53. Frigo P, Eppel W, Asseryanis E, Sator M, Golaszewski T, Gruber D, Lang C and Huber J: The effects of hormone substitution in depot form on the uterus in a group of 50 perimenopausal women, a vaginosonographic study. Maturitas 21: 221-225, 1995.
54. Sener AB, Seckin NC, Ozmen S, Gokmen O, Dogu N and Ekici E: The effects of hormone replacement therapy on uterine fibroids in postmenopausal women. Fertil Steril 65: 354-357, 1996.
55. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjöblom P, Norgren A and Lindblom B: Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab 83: 4092-4096, 1998.
56. Hoekstra AV, Sefton EC, Berry E, Lu Z, Hardt J, Marsh E, Yin P, Clardy J, Chakravarti D, Bulun S and Kim JJ: Progestins activate the AKT pathway in leiomyoma cells and promote survival. J Clin Endocrinol Metab 94: 1768-1774, 2009.
57. Ying Z and Weiyuan Z: Dual actions of progesterone on uterine leiomyoma correlate with the ratio of progesterone receptor A:B. Gynecol Endocrinol 25: 520-523, 2009.
58. Tamaya T, Fujimoto J and Okada H: Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium. Acta Obstet Gynecol Scand 64: 307-309, 1985.
59. Fujimoto J, Nishigaki M, Hori M, Ichigo S, Itoh T and Tamaya T: The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects. J Steroid Biochem Mol Biol 50: 137-143, 1994.
60. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR and Anderson S: Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101: 1455-1462, 2004.
61. Van Voorhis BJ, Romitti PA and Jones MP: Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 47: 663-669, 2002.
62. Sato F, Mori M, Nishi M, Kudo R and Miyake H: Familial aggregation of uterine myomas in Japanese women. J Epidemiol 12: 249-253, 2002.
63. Okolo SO, Gentry CC, Perrett CW and Maclean AB: Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features. Hum Reprod 20: 2321-2324, 2005.
64. Uimari O, Suomalainen-König S, Sakkinen N, Santala M, Nieminen P and Ryynanen M: Natural history of familial myomas. Eur J Obstet Gynecol Reprod Biol 125: 255-258, 2006.
65. Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, Girão MJ, Nishimura E, Baracat EC and Silva ID: Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 7: 11-12, 2006.
66. Hsieh YY, Wang YK, Chang CC and Lin CS: Estrogen receptor alpha-351 Xba I*G and -397 Pvu II*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 13: 117-122, 2007.
67. Gomes MT, Castro Rde A, Villanova FE, da Silva ID, Baracat EC, de Lima GR and Girão MJ: The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids. Fertil Steril 87: 1116-1121, 2007.
68. Renner SP, Strick R, Fasching PA, Oeser S, Oppelt P, Mueller A, Beckmann MW and Strissel PL: Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk. Am J Obstet Gynecol 199: 648.e1-648.e9, 2008.
69. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS and Peng CT: Androgen receptor trinucleotide polymorphism in leiomyoma. J Assist Reprod Genet 21: 453-457, 2004.
70. Rosa FE, Canevari Rde A, Ambrosio EP, Ramos Cirilo PD, Pontes A, Rainho CA and Rogatto SR: Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas. Clin Chem Lab Med 46: 814-823, 2008.